EVM
LH icon

Eaton Vance Management’s Labcorp LH Stock Holding History

Eaton Vance Management’s Portfolio LH Stock Details LH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$13.6M Buy
77,512
+726
+0.9% +$149K 0.02% 527
2022
Q2 		$15.5M Sell
76,786
-2,324
-3% -$495K 0.02% 517
2022
Q1 		$17.9M Buy
79,110
+59,000
+293% +$13.9M 0.02% 529
2021
Q4 		$5.43M Buy
20,110
+39
+0.2% +$9.65K 0.01% 769
2021
Q3 		$4.38M Sell
20,071
-292
-1% -$73.6K 0.01% 752
2021
Q2 		$4.83M Buy
20,363
+1,392
+7% +$317K 0.01% 792
2021
Q1 		$4.16M Buy
18,971
+932
+5% +$187K 0.01% 787
2020
Q4 		$3.15M Sell
18,039
-318
-2% -$54.9K 0.01% 824
2020
Q3 		$2.97M Buy
18,357
+585
+3% +$92.7K 0.01% 743
2020
Q2 		$2.54M Buy
17,772
+192
+1% +$26.6K 0.01% 753
2020
Q1 		$1.91M Buy
17,580
+350
+2% +$50.4K ﹤0.01% 768
2019
Q4 		$2.5M Buy
17,230
+664
+4% +$95.9K ﹤0.01% 784
2019
Q3 		$2.39M Buy
16,566
+24
+0.1% +$3.5K 0.01% 770
2019
Q2 		$2.46M Buy
16,542
+190
+1% +$26.5K 0.01% 758
2019
Q1 		$2.15M Buy
16,352
+926
+6% +$114K ﹤0.01% 752
2018
Q4 		$1.68M Buy
15,426
+73
+0.5% +$9.78K ﹤0.01% 767
2018
Q3 		$2.29M Hold
15,353
– – 0.01% 731
2018
Q2 		$2.37M Sell
15,353
-15,079
-50% -$2.28M 0.01% 702
2018
Q1 		$4.23M Buy
30,432
+15,216
+100% +$2.24M 0.01% 702
2017
Q4 		$2.08M Buy
15,216
+694
+5% +$91.7K 0.01% 701
2017
Q3 		$1.88M Sell
14,522
-118
-0.8% -$15.7K ﹤0.01% 707
2017
Q2 		$1.94M Buy
14,640
+10,244
+233% +$1.25M 0.01% 691
2017
Q1 		$542K Sell
4,396
-85
-2% -$10.1K ﹤0.01% 887
2016
Q4 		$494K Buy
4,481
+85
+2% +$9.44K ﹤0.01% 861
2016
Q3 		$519K Buy
4,396
+51
+1% +$6.01K ﹤0.01% 838
2016
Q2 		$486K Buy
4,345
+27
+0.6% +$2.91K ﹤0.01% 821
2016
Q1 		$435K Buy
4,318
+174
+4% +$16.7K ﹤0.01% 810
2015
Q4 		$440K Sell
4,144
-424
-9% -$43.7K ﹤0.01% 822
2015
Q3 		$426K Hold
4,568
– – ﹤0.01% 810
2015
Q2 		$476K Hold
4,568
– – ﹤0.01% 763
2015
Q1 		$495K Buy
+4,568
New +$470K ﹤0.01% 790

Other funds holding LH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Eaton Vance Management's LH Position: Q3 2022 in Review

Eaton Vance Management increased its Labcorp (LH) stake by 0.95% in Q3 2022, buying an estimated $149K and bringing the position to 77,512 shares worth $13.6M. The position accounts for 0.02% of the portfolio, ranked #527.

Eaton Vance Management first reported a position in LH in Q1 2015 and has held it in 31 quarters since. The position peaked at $17.9M in Q1 2022. 936 funds tracked by Wall St. Rank hold LH as of Q3 2022.

  • Eaton Vance Management held 77,512 shares of Labcorp worth $13.6M as of Q3 2022.
  • Eaton Vance Management bought 726 Labcorp shares in Q3 2022, an estimated $149K.
  • Labcorp made up 0.02% of Eaton Vance Management's portfolio in Q3 2022, its #527 holding.
  • Eaton Vance Management first reported a position in Labcorp in Q1 2015 and has held it in 31 quarters since.
  • Eaton Vance Management's Labcorp position peaked at $17.9M in Q1 2022.
  • 936 funds tracked by Wall St. Rank held Labcorp as of Q3 2022.

Based on Eaton Vance Management's 13F filing for Q3 2022, filed 14 Nov 2022.